Buzz Carter, Author at Hlx Life Sciences

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer Read more

The future of RAS inhibitors Read more

Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'? Read more

About Buzz Carter

This author has not yet filled in any details.
So far Buzz Carter has created 2 blog entries.

Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health
Gallery
Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health

Brain Belt 50

Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health

“You Have to Be Completely Crazy” – Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health From the ER to entrepreneurship, [...]

Buzz Carter2025-09-02T10:22:17+01:00July 29, 2025|

Case Study: Hlx Life Sciences Secures Major Partnership by Redefining Talent Solutions
Gallery
Case Study: Hlx Life Sciences Secures Major Partnership by Redefining Talent Solutions

Case Study

Case Study: Hlx Life Sciences Secures Major Partnership by Redefining Talent Solutions

Two weeks ago, Hlx Life Sciences established an exciting new partnership with a biotech company that had recently raised a significant Series B funding [...]

Buzz Carter2024-10-16T15:48:59+01:00October 16, 2024|

About Buzz Carter

Lara Zibners on What It Takes to Build Biotech Breakthroughs in Women’s Health

Case Study: Hlx Life Sciences Secures Major Partnership by Redefining Talent Solutions

Contractors

Clients

Legal

Contact Us